EV/EBITDA
-1.50
-0.01-0.67%
Thu, 28 Nov 2024 00:16:16 GMT
Summary:
BioXcel Therapeutics EV/EBITDA is currently -1.50, with a fall of -0.01 (-0.67%) during the most recent trading day. Over the past year, it has dropped by -0.89 (-145.90%). BTAI EV/EBITDA is now -341.94% below its all-time high of 0.62.BTAI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTAI EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | -0.7% |
1 m1 month | +8.5% |
3 m3 months | -89.9% |
6 m6 months | -111.3% |
ytdytd | -100.0% |
1 y1 year | -145.9% |
5 y5 years | +35.9% |
BTAI EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -1.49 | -0.7% | -1.71 | +12.3% |
3 m | 3 months | -0.73 | -105.5% | -1.71 | +12.3% |
6 m | 6 months | -0.51 | -194.1% | -1.71 | +12.3% |
1 y | 1 year | -0.49 | -206.1% | -1.71 | +12.3% |
3 y | 3 years | -0.23 | -552.2% | -5.42 | +72.3% |
5 y | 5 years | -0.23 | -552.2% | -27.27 | +94.5% |
alltime | all time | 0.62 | -341.9% | -37.94 | +96.0% |
BioXcel Therapeutics EV/EBITDA History
Date | Value |
---|---|
2024 | -1.50(+100.0%) |
2023 | -0.75(-76.3%) |
2022 | -3.17(+0.3%) |
Date | Value |
---|---|
2021 | -3.16(-71.7%) |
2020 | -11.18(+59.0%) |
2019 | -7.03(+681.1%) |
2018 | -0.90 |
FAQ
- What is BioXcel Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for BioXcel Therapeutics?
- What is BTAI EV/EBITDA year-to-date change?
- What is BioXcel Therapeutics EV/EBITDA year-on-year change?
What is BioXcel Therapeutics EV/EBITDA?
The current EV/EBITDA of BTAI is -1.50
What is the all time high EV/EBITDA for BioXcel Therapeutics?
BioXcel Therapeutics all-time high EV/EBITDA is 0.62
What is BTAI EV/EBITDA year-to-date change?
BioXcel Therapeutics EV/EBITDA has changed by -0.75 (-100.00%) since the beginning of the year
What is BioXcel Therapeutics EV/EBITDA year-on-year change?
Over the past year, BTAI EV/EBITDA has changed by -0.89 (-145.90%)